Natera Inc (NTRA)
176.61
+6.21
(+3.64%)
USD |
NASDAQ |
Jan 08, 16:00
180.00
+3.39
(+1.92%)
After-Hours: 20:00
Natera Research and Development Expense (Quarterly): 96.93M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Guardant Health Inc | 87.31M |
Progyny Inc | -- |
Delcath Systems Inc | 3.866M |
Star Equity Holdings Inc | -- |
CytoSorbents Corp | 1.851M |